Purulent infectious myositis (formerly tropical pyomyositis)

Area of Science:

• Infectious Diseases
• Musculoskeletal Disorders
• Microbiology

Background:

• Purulent infectious myositis (PIM), previously tropical pyomyositis, is a pyogenic skeletal muscle infection.
• Staphylococcus aureus is the primary pathogen, though other microorganisms can be involved.
• PIM presents as a febrile illness with muscle pain, but can be severe, especially in immunocompromised individuals and children.

Purpose of the Study:

• To review purulent infectious myositis (PIM).
• Highlighting its global distribution, causative agents, predisposing factors, management, and potential complications.

Main Methods:

• Review of existing literature on PIM.
• Analysis of diagnostic imaging modalities.
• Evaluation of treatment strategies including antimicrobial therapy and surgical drainage.

Main Results:

• PIM diagnosis can be challenging due to subtle skin changes, necessitating a high index of suspicion.
• Imaging like ultrasonography, CT, and MRI are vital for diagnosis.
• Treatment involves surgical drainage and culture-guided antibiotics, with vancomycin recommended for MRSA strains.

Conclusions:

• Prompt diagnosis and appropriate management are essential for favorable outcomes in PIM.
• The increasing prevalence of MRSA necessitates updated treatment guidelines.
• Understanding PIM's epidemiology and risk factors aids in prevention and control efforts.